Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Documentation

  • Home >
  • Investors & media >
  • Documentation
14 June 2023
Financial statements and reports, General Assembly, General meetings

Supplementary report of the Board of Director dated 23 March 2023 Open in new window

14 June 2023
Financial statements and reports, General Assembly, General meetings

Supplementary report of the Board of Director dated 22 December 2022 Open in new window

31 May 2023
General Assembly

Auditors’ report on resolution number 16 to 18 and 21 Open in new window

31 May 2023
General Assembly

Auditors’ report on resolution number 24 Open in new window

31 May 2023
General Assembly

Auditors’ report on resolution number 20 Open in new window

31 May 2023
General Assembly

Auditors’ report on resolution number 19 Open in new window

31 May 2023
General Assembly, General meetings

Notice of General Meeting to be held on the 21th of June, 2023 Open in new window

31 May 2023
General Assembly, General meetings

Auditors’ report on resolution number 14 Open in new window

31 May 2023
General Assembly, General meetings

Nominees to the Board of Directors – 2022 General Meeting Open in new window

31 May 2023
General Assembly, General meetings

Auditors’ special report on 2022 related party agreements Open in new window

  • View previous 9 articles
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 23
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page